RxDoctor Payments Data

Jack Klapper

Jefferson, CONPI 1871936278

Payments from drug & device makers

What this record shows

This record is dominated by education: $30 of the $30 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Eisai Inc..

$30in general payments, 2019–2025

Across 1 payment — averaging $30.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$30
$1,307,358in research payments, 2019–2025

Across 299 payments — averaging $4372.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eisai Inc.$1.3M
  • Eli Lilly$5K
  • Novo Nordisk AS$3K
  • Genentech, Inc.$400

What the payments were for

  • Education$30100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.1$30

Where these figures come from

Is this you, or does something look wrong? →